NASDAQ:REGN

Regeneron Pharmaceuticals Stock News

etoro logo Buy REGN
*Your capital is at risk
$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026
Is (REGN) Outperforming Other Medical Stocks This Year?

7 Gene Editing Stocks Promising to Change our DNA

12:45pm, Wednesday, 15'th Sep 2021
Gene editing stocks will take off as the underlying tech moves from fiction to fact and companies put their products on the market. The post 7 Gene Editing Stocks Promising to Change our DNA appeared
Shares of Regeneron Pharmaceuticals Inc. REGN, +0.88% gained 2.1% in premarket trading on Wednesday, the day after the company said the U.S. government had purchased an additional 1.4 million doses of
TARRYTOWN, N.Y., Sept. 14, 2021 /PRNewswire/ -- New agreement for 1.4 million doses of REGEN-COV, brings total purchased by the U.S. government to nearly 3 million doses REGEN-COV currently authorized
In the latest trading session, Regeneron (REGN) closed at $639.52, marking a -1.69% move from the previous day.
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)
TARRYTOWN, N.Y., Sept. 8, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Morgan Stanley 19th Annual Global Healthcare Conference
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. REGN, CAJ, COG, EXC & WMT are well poised to gain.

My Fat-Margin Stocks Returned 78% Last Year

10:46am, Tuesday, 07'th Sep 2021
It's been a great year for stocks with fat profit margins.
REGN, MRNA & VRTX are the three biotech companies that are likely to outperform the sector on the back of strong fundamentals.
Their products are seeing a surge in demand.

Antibody drugs take off in new Covid surge

03:23pm, Tuesday, 31'st Aug 2021
Meg Tirrell joins The Exchange with more information about Covid antibody treatments and the increasing demand for these drugs in places where the delta variant is surging. For access to live and excl
Is (REGN) Outperforming Other Medical Stocks This Year?
Sanofi (SNY) and Regeneron (REGN)'s Dupixent meet all primary and secondary endpoints in phase III study to treat children aged six months to five years with moderate-to-severe atopic dermatitis.

Coronavirus antibody drugs take off

10:49am, Monday, 30'th Aug 2021
CNBC's Meg Tirrell reports on the surge in Covid antibody drug orders.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE